Medical News

Filed under: Bladder Cancer, Clinical Trials, Research

Herceptin (trastuzumab) is a targeted therapy used for treatment of HER2 positive breast cancer. Results of a Phase II clinical trial showed that Herceptin might have a roll in treating patients with HER2 positive advanced bladder cancer.

The researchers conducted the clinical trial to examine the effectiveness of Herceptin along with chemotherapy in a little under fifty patients with advanced bladder cancer. The chemotherapy given with the Herceptin was paclitaxel, carboplatin, and gemcitabine.

This was a small study and research will have to continue to see if this treatment is something that will be put into mainstream use. The study concluded that:

• 11 percent of patients experienced a complete disappearance of detectable cancer.
• 59 percent of patients experienced a partial disappearance of detectable cancer.

Read | Permalink | Email this | Linking Blogs | Comments

Original post by Kristina Collins

Filed under: Bladder Cancer, Clinical Trials, Research

Herceptin (trastuzumab) is a targeted therapy used for treatment of HER2 positive breast cancer. Results of a Phase II clinical trial showed that Herceptin might have a roll in treating patients with HER2 positive advanced bladder cancer.

The researchers conducted the clinical trial to examine the effectiveness of Herceptin along with chemotherapy in a little under fifty patients with advanced bladder cancer. The chemotherapy given with the Herceptin was paclitaxel, carboplatin, and gemcitabine.

This was a small study and research will have to continue to see if this treatment is something that will be put into mainstream use. The study concluded that:

• 11 percent of patients experienced a complete disappearance of detectable cancer.
• 59 percent of patients experienced a partial disappearance of detectable cancer.

Read | Permalink | Email this | Linking Blogs | Comments

Original post by Kristina Collins